Found 74 matching trials
Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore PHASE2 This is a single-arm, open-label, multi-center clinical study to evaluate t...
Show More Location
Nanfang Hospital, Southern Medical University
Learn More & Join Trial
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma PHASE2 This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer PHASE3 This is a randomized, prospective, multicenter, open-label, Phase III clini...
Show More Status
Active Not Recruiting
Location
Sir Run Run Shao hospital
Learn More & Join Trial
Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer PHASE2 This study is a single-center, prospective, open-label, randomized controll...
Show More Location
Fourth Hospital of Hebei Medical University
Learn More & Join Trial
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer(CONTROL-01) PHASE2 To evaluate the safety and preliminary efficacy of preoperative chemotherap...
Show More Location
The affiliated hospital of Qingdao university
Learn More & Join Trial
Tislelizumab Combined With Anlotinib and Chemotherapy (XELOX) in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (TALENT) PHASE1 This is a Phase 2, multi-cohort study to investigate safety, anti-tumor act...
Show More Location
The First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer. PHASE2 SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction PHASE2 The investigators will conduct a prospective phase 2 study to evaluate the ...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
A Benefit Population Atlas of nICT Versus nCT for LAGC N/A The purpose of this observational study is to evaluate the impact of differ...
Show More Location
Jiangsu Cancer Hospital
Learn More & Join Trial
Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer PHASE2 This study is a multi-center, single-arm, open-label phase II clinical tria...
Show More Location
Multiple Locations
Learn More & Join Trial